Check out our most popular compounded medications! Get Started
Bayview Pharmacy's Acetazalolamide 150 mg/ml Oral Suspension (Vet-Equine) is a compounded liquid medication, uniformly dispersed for consistent dosing. It is used in the treatment of various equine conditions such as Recurrent Uveitis, Metabolic Syndrome, Cushing's Syndrome, Hyperkalemic Periodic Paralysis, and Idiopathic Head Tremor.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Acetazolamide 150 mg/ml Oral Suspension (Vet-Equine) is a specially compounded medication designed for the treatment of various equine diseases. This formulation is a liquid dosage form in which the active ingredient, acetazolamide, is uniformly dispersed throughout a liquid medium. This ensures a homogeneous mixture for administration, providing a consistent dose of medication with each use.
Acetazolamide is a carbonic anhydrase inhibitor that is commonly used to treat conditions such as glaucoma, edema, and seizures in horses. Additionally, it is utilized to reduce the risk of altitude sickness in horses, making it a versatile medication for equine health. The oral suspension form of this medication offers a convenient method of administration, making it easier for horse owners and veterinarians to ensure the horse receives the necessary treatment.
The recommended dosage of Acetazolamide 150 mg/ml Oral Suspension (Vet-Equine) is 1-2 ml per 100 lbs of body weight, administered orally once daily. It is crucial to adhere to the veterinarian's instructions when administering this medication to ensure the horse's safety and the effectiveness of the treatment. Monitoring the horse for any adverse reactions or side effects is also essential to promptly address any potential health concerns.
If you have any questions about this formulation or its administration, please do not hesitate to contact us at Bayview Pharmacy. Our team is ready to assist you with any inquiries you may have regarding this medication.
Acetazolamide 150 mg/ml Oral Suspension (Vet-Equine) is a compounded formulation that is known to interact with various other medications. These include diuretics, corticosteroids, anticonvulsants, antacids, aspirin, and nonsteroidal anti-inflammatory drugs (NSAIDs). It is crucial for patients to inform their healthcare provider of any other medications they are currently taking before initiating treatment with Acetazolamide.
When taken with diuretics, corticosteroids, or anticonvulsants, Acetazolamide may increase the risk of hypokalemia, hyperglycemia, hyponatremia, hyperuricemia, and hypomagnesemia. Patients should closely monitor their electrolyte, blood sugar, sodium, uric acid, and magnesium levels when taking these medications in combination with Acetazolamide.
Acetazolamide may also interact with antacids, aspirin, or NSAIDs, potentially increasing the risk of hyperkalemia, hypocalcemia, and hypomagnesemia. Patients should closely monitor their electrolyte, calcium, and magnesium levels when taking these medications in combination with Acetazolamide.
If you have any questions about the potential interactions of Acetazolamide 150 mg/ml Oral Suspension (Vet-Equine) and other medications, please consult with your healthcare provider. It is essential to understand these potential interactions to ensure safe and appropriate use of this medication.
Acetazolamide 150 mg/ml Oral Suspension (Vet-Equine) is a liquid medication specifically formulated for horses. It is used to treat a range of conditions including glaucoma, seizures, and altitude sickness. The active ingredient, Acetazolamide, works by inhibiting the enzyme carbonic anhydrase, which plays a crucial role in regulating fluid balance within the body. By doing so, it helps to alleviate the pressure in the eye, reduce the frequency of seizures, and mitigate the symptoms of altitude sickness.
When administering Acetazolamide 150 mg/ml Oral Suspension (Vet-Equine), it is crucial to adhere to the instructions provided by your veterinarian. The medication should be given orally, typically once or twice a day. The exact dosage and frequency of administration will be determined by the condition being treated and the horse's response to the medication. It is essential to administer the medication as prescribed and refrain from altering the dose or frequency without first consulting your veterinarian.
As with any medication, it is important to closely monitor your horse for any potential side effects. Common side effects may include loss of appetite, diarrhea, and vomiting. Should any of these side effects occur, it is imperative to contact your veterinarian immediately.
If you have any queries regarding Acetazolamide 150 mg/ml Oral Suspension (Vet-Equine) or its mechanism of action, please do not hesitate to reach out. We are committed to providing the best possible care for you and your horse.
Acetazolamide 150 mg/ml Oral Suspension (Vet-Equine) is a versatile medication used to manage a variety of health conditions in horses. It is commonly used to treat glaucoma, a condition that causes increased pressure in the eye, and edema, which is characterized by an excess of watery fluid collecting in the cavities or tissues of the body.
For horses traveling to high altitudes, Acetazolamide can be used to reduce the risk of altitude sickness. It is also beneficial in preventing kidney stones in horses prone to recurrent urolithiasis, a condition characterized by the formation of stones in the urinary tract.
Acetazolamide is also used to manage metabolic syndrome in horses, reducing the risk of hypokalemia, a condition characterized by low potassium levels in the blood. Conversely, it can also be used to reduce the risk of hyperkalemia in horses with hyperkalemic periodic paralysis, a muscle disorder that causes episodes of extreme muscle weakness or paralysis.
For horses suffering from idiopathic head tremors, Acetazolamide can help reduce the risk of these tremors. It is also used to decrease the risk of recurrence of uveitis, an inflammation of the middle layer of the eye, in horses with a history of this condition.
Acetazolamide can also be used in the management of Cushing's Syndrome in horses, reducing the risk of recurrence of this endocrine disorder. It is also used to reduce the risk of recurrence of metabolic syndrome in horses diagnosed with this condition.
If you have any questions about the use of Acetazolamide 150 mg/ml Oral Suspension (Vet-Equine) for any of these conditions, please do not hesitate to contact us.
Acetazolamide 150 mg/ml Oral Suspension (Vet-Equine) is a liquid dosage form of medication specifically designed for horses. It contains the active ingredient Acetazolamide uniformly dispersed throughout a liquid medium, providing a homogeneous mixture for administration.
This medication is administered orally. The uniform dispersion of the active ingredient in the liquid medium ensures that the horse receives the correct dosage.
Acetazolamide is a medication that is used to treat a variety of conditions in horses, including glaucoma, fluid retention, and certain types of seizures. It works by reducing the amount of fluid that can build up in the horse's eyes or body.
The suspension form of this medication ensures that the active ingredient is uniformly dispersed throughout the liquid medium. This allows for easier administration and ensures that the horse receives the correct dosage.
While Acetazolamide is used in various species, this specific formulation is designed for horses. Always consult with a veterinarian before administering any medication to ensure it is safe and appropriate for the specific animal.
Side effects can include loss of appetite, lethargy, and changes in blood chemistry. If you notice any adverse reactions, contact your veterinarian immediately.
Acetazolamide 150 mg/ml Oral Suspension (Vet-Equine) should be stored at room temperature, away from light and moisture. Always keep out of reach from children and pets.
If you miss a dose, give it as soon as you remember. If it is close to the time for the next dose, skip the missed dose and go back to the regular dosing schedule. Do not give two doses at once.
Consult with your veterinarian before using this medication in pregnant or lactating mares, as Acetazolamide can pass into milk and may affect the foal.
If you suspect an overdose, contact your veterinarian immediately. Symptoms of an overdose may include loss of appetite, lethargy, and changes in blood chemistry.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take orally
